(PRESS RELEASE) LONDON, 10-Feb-2022 — /EuropaWire/ — Rolls-Royce (LSE:RR., ADR:RYCEY), the pre-eminent engineering company with focus on world-class power and propulsion systems, has announced it completed the sale of its 23.1% shareholding in AirTanker Holdings Limited, a leading aviation service … Read the full press release
Posted in Aviation & Aerospace, Business, Defence, Industrial, Investment, News, Technology, United Kingdom
Tagged A330-200, air transport, air-to-air refuelling, AirTanker Holdings Limited, ancillary, Equitix Investment Management Limited, Rolls-Royce, Royal Air Force, Shareholding, Trent 700 engine, Trent 772B engines, UK Ministry of Defence, Voyager aircraft
(PRESS RELEASE) LONDON, 13-Sep-2021 — /EuropaWire/ — Rolls-Royce (LSE:RR., ADR:RYCEY), the pre-eminent engineering company with focus on world-class power and propulsion systems, has announced the sale of its 23.1% shareholding in AirTanker Holdings Limited to Equitix Investment Management Limited for … Read the full press release
Posted in Aviation & Aerospace, Business, Industrial, Investment, News, Transportation & Logistics, United Kingdom
Tagged 14 A330-200 Voyager aircraft, air transport, air-to-air refuelling, Airbus, AirTanker Holdings Limited, AirTanker Services Limited, ancillary services, Babcock, Equitix Investment Management Limited, Rolls-Royce, Royal Air Force, Shareholding, shares, Thales, Tom Bell, Trent 700 engine, Trent 772B engines, UK Ministry of Defence, Voyager aircraft
Westhampnett, United Kingdom, 09-Feb-2018 — /EuropaWire/ — Rolls-Royce today signed contracts with Singapore Airlines at the Singapore Airshow covering Trent 1000 and Trent 700 engines. Singapore Airlines formally confirmed a $1.7bn order for Trent 1000 engines to power 19 Boeing … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
